Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Collegium Pharma (COLL)

Collegium Pharma (COLL)
25.91 +1.24 (+5.03%) 14:02 ET [NASDAQ]
25.76 x 400 25.84 x 100
Realtime by (Cboe BZX)
25.76 x 400 25.84 x 100
Realtime 25.20 +0.53 (+2.15%) 06:46 ET
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
24.47
Day High
25.86
Open 24.98
Previous Close 24.67 24.67
Volume 289,509 289,509
Avg Vol 472,720 472,720
Stochastic %K 25.90% 25.90%
Weighted Alpha -34.14 -34.14
5-Day Change -2.90 (-10.31%) -2.90 (-10.31%)
52-Week Range 23.23 - 42.29 23.23 - 42.29
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 792,696
  • Shares Outstanding, K 32,132
  • Annual Sales, $ 631,450 K
  • Annual Income, $ 69,190 K
  • EBIT $ 167 M
  • EBITDA $ 334 M
  • 60-Month Beta 0.76
  • Price/Sales 1.34
  • Price/Cash Flow 2.14
  • Price/Book 3.72

Options Overview Details

View History
  • Implied Volatility 78.84% ( +6.59%)
  • Historical Volatility 41.79%
  • IV Percentile 98%
  • IV Rank 91.33%
  • IV High 83.66% on 05/21/24
  • IV Low 27.97% on 09/20/24
  • Put/Call Vol Ratio 1.00
  • Today's Volume 4
  • Volume Avg (30-Day) 13
  • Put/Call OI Ratio 0.48
  • Today's Open Interest 402
  • Open Int (30-Day) 496

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.34
  • Number of Estimates 4
  • High Estimate 1.52
  • Low Estimate 1.20
  • Prior Year 1.32
  • Growth Rate Est. (year over year) +1.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.23 +8.65%
on 04/10/25
Period Open: 29.99
30.84 -18.16%
on 03/24/25
-4.75 (-15.84%)
since 03/11/25
3-Month
23.23 +8.65%
on 04/10/25
Period Open: 32.91
34.06 -25.90%
on 01/28/25
-7.67 (-23.31%)
since 01/10/25
52-Week
23.23 +8.65%
on 04/10/25
Period Open: 36.39
42.29 -40.31%
on 10/07/24
-11.15 (-30.64%)
since 04/11/24

Most Recent Stories

More News
A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

RPRX : 31.76 (+1.76%)
COLL : 25.91 (+5.03%)
SUPN : 31.43 (+1.16%)
OGN : 11.21 (-1.92%)
ZTS : 148.74 (+1.18%)
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference

COLL : 25.91 (+5.03%)
Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting

COLL : 25.91 (+5.03%)
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

BHVN : 17.65 (+3.04%)
COLL : 25.91 (+5.03%)
TRVI : 5.37 (+1.70%)
AVTX : 4.86 (-1.62%)
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

RPRX : 31.76 (+1.76%)
COLL : 25.91 (+5.03%)
SUPN : 31.43 (+1.16%)
OGN : 11.21 (-1.92%)
ZTS : 148.74 (+1.18%)
Collegium Announces Updates to its Board of Directors and Executive Leadership Team

COLL : 25.91 (+5.03%)
Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

COLL : 25.91 (+5.03%)
Collegium to Participate in Upcoming Investor Conferences

COLL : 25.91 (+5.03%)
Collegium Pharmaceutical: Q4 Earnings Snapshot

Collegium Pharmaceutical: Q4 Earnings Snapshot

COLL : 25.91 (+5.03%)
Collegium Pharmaceutical’s (NASDAQ:COLL) Q4 Sales Top Estimates, Stock Jumps 14.1%

Collegium Pharmaceutical’s (NASDAQ:COLL) Q4 Sales Top Estimates, Stock Jumps 14.1%

COLL : 25.91 (+5.03%)

Business Summary

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171,...

See More

Key Turning Points

3rd Resistance Point 28.79
2nd Resistance Point 27.39
1st Resistance Point 26.03
Last Price 25.91
1st Support Level 23.27
2nd Support Level 21.87
3rd Support Level 20.51

See More

52-Week High 42.29
Fibonacci 61.8% 35.01
Fibonacci 50% 32.76
Fibonacci 38.2% 30.51
Last Price 25.91
52-Week Low 23.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar